CRISPR-Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges.
Saved in:
| Title: | CRISPR-Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges. |
|---|---|
| Authors: | Yashooa RK; Department of Biology, College of Education for Pure Sciences, University of Al-Hamdaniya, Mosul, Iraq., Nabi AQ; Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Iraq., Smail SW; College of Pharmacy, Cihan University-Erbil, Erbil, Iraq., Azeez SS; Department of Medical Laboratory Technology, Soran Technical College, Erbil Polytechnic University, Erbil, Iraq., Nooh WA; Department of Biology, College of Education for Pure Sciences, University of Al-Hamdaniya, Mosul, Iraq., Mustafa SA; General Directorate of Scientific Research Center, Salahaddin University-Erbil, Erbil, Iraq., Al-Farha AA; Department of Biotechnology and Food Sciences, Technical Agricultural College-Mosul, Northern Technical University, Mosul, Iraq., Capitanio N; Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy., Shekha MS; Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Iraq.; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. |
| Source: | Frontiers in neurology [Front Neurol] 2026 Jan 27; Vol. 16, pp. 1737468. Date of Electronic Publication: 2026 Jan 27 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
